Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments

BACKGROUND: Inhaled corticosteroid/long-acting β(2)-agonist combinations and/or long-acting muscarinic antagonists are recommended first-line therapies for preventing chronic obstructive pulmonary disease (COPD) exacerbation. Comparative effectiveness of budesonide/formoterol combination (BFC, an in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Chron Obstruct Pulmon Dis
Autors principals: Trudo, Frank, Kern, David M, Davis, Jill R, Tunceli, Ozgur, Zhou, Siting, Graham, Emma L, Strange, Charlie, Williams, Setareh A
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4592033/
https://ncbi.nlm.nih.gov/pubmed/26451101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S90658
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars